Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,473 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.
Wong NKY, Llaurado Fernandez M, Kommoss FKF, Praveen Kumar P, Kim H, Liu J, Zhang G, Coatham M, Lin YY, Haegert AM, Volik S, Le Bihan S, Collins CC, Fu Y, Postovit LM, von Deimling A, Wu R, Xue H, Wang Y, Köbel M, Carey MS, Lee CH. Wong NKY, et al. Among authors: lin yy. Gynecol Oncol. 2023 Sep;176:162-172. doi: 10.1016/j.ygyno.2023.07.016. Epub 2023 Aug 7. Gynecol Oncol. 2023. PMID: 37556934
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma.
Shrestha R, Nabavi N, Lin YY, Mo F, Anderson S, Volik S, Adomat HH, Lin D, Xue H, Dong X, Shukin R, Bell RH, McConeghy B, Haegert A, Brahmbhatt S, Li E, Oo HZ, Hurtado-Coll A, Fazli L, Zhou J, McConnell Y, McCart A, Lowy A, Morin GB, Chen T, Daugaard M, Sahinalp SC, Hach F, Le Bihan S, Gleave ME, Wang Y, Churg A, Collins CC. Shrestha R, et al. Among authors: lin d, lin yy. Genome Med. 2019 Feb 18;11(1):8. doi: 10.1186/s13073-019-0620-3. Genome Med. 2019. PMID: 30777124 Free PMC article.
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Shrestha R, Llaurado Fernandez M, Dawson A, Hoenisch J, Volik S, Lin YY, Anderson S, Kim H, Haegert AM, Colborne S, Wong NKY, McConeghy B, Bell RH, Brahmbhatt S, Lee CH, DiMattia GE, Le Bihan S, Morin GB, Collins CC, Carey MS. Shrestha R, et al. Among authors: lin yy. Cancer Res. 2021 Apr 1;81(7):1681-1694. doi: 10.1158/0008-5472.CAN-20-2222. Epub 2021 Jan 13. Cancer Res. 2021. PMID: 33441310
Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria.
Slavin YN, Ivanova K, Hoyo J, Perelshtein I, Owen G, Haegert A, Lin YY, LeBihan S, Gedanken A, Häfeli UO, Tzanov T, Bach H. Slavin YN, et al. Among authors: lin yy. ACS Appl Mater Interfaces. 2021 May 19;13(19):22098-22109. doi: 10.1021/acsami.0c16921. Epub 2021 May 4. ACS Appl Mater Interfaces. 2021. PMID: 33945683 Free article.
Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.
Okasho K, Mizuno K, Fukui T, Lin YY, Kamiyama Y, Sunada T, Li X, Kimura H, Sumiyoshi T, Goto T, Kobayashi T, Lin D, Wang Y, Collins CC, Inoue T, Ogawa O, Akamatsu S. Okasho K, et al. Among authors: lin d, lin yy. Cancer Sci. 2021 Jul;112(7):2781-2791. doi: 10.1111/cas.14935. Epub 2021 Jun 1. Cancer Sci. 2021. PMID: 33960594 Free PMC article.
1,473 results